telomerase

telomerase is a ribonucleoprotein complex, specifically a reverse transcriptase, that adds DNA sequence repeats to the 3' end of chromosomes. This enzymatic activity counteracts the progressive shortening of telomeres that occurs during DNA replication in most somatic cells. The discovery of telomerase, for which Elizabeth Blackburn, Carol Greider, and Jack Szostak were awarded the Nobel Prize in Physiology or Medicine in 2009, fundamentally altered understanding of cellular aging and carcinogenesis.

Structure and mechanism

The core functional components of telomerase are a catalytic protein subunit and an essential RNA molecule. The protein component, known as TERT (Telomerase Reverse Transcriptase), provides the enzymatic activity. The RNA component, called TERC (Telomerase RNA Component), contains a template region complementary to the telomeric repeat sequence, such as TTAGGG in vertebrates. Additional associated proteins, including dyskerin, NOP10, NHP2, and GAR1, form the H/ACA box ribonucleoprotein complex that stabilizes TERC. The enzyme binds to the single-stranded overhang of a telomere via its RNA template, and TERT synthesizes new DNA repeats using deoxynucleotide triphosphates. This process, termed telomere elongation, involves repeated cycles of translocation and synthesis.

Biological function and regulation

Telomerase activity is crucial for maintaining genomic stability in rapidly dividing cells, such as germ line cells, stem cells, and certain immune cells. Its expression is tightly regulated during development and across different tissue types. In most human somatic cells, TERT expression is repressed, leading to progressive telomere attrition with each cell division. Key regulators include tumor suppressor proteins like p53 and RB1, as well as oncogenes such as MYC. The shelterin complex, comprising proteins like TRF1, TRF2, and POT1, protects telomeres and modulates access of telomerase to the chromosome end. Environmental factors and oxidative stress can also influence telomerase activity and telomere dynamics.

Role in aging and disease

Progressive telomere shortening in the absence of sufficient telomerase activity is a primary molecular mechanism underlying cellular senescence and is implicated in the aging process. Critically short telomeres trigger a persistent DNA damage response, leading to cell cycle arrest. This process contributes to age-related decline in tissue function. Mutations in genes encoding telomerase components or associated proteins cause a spectrum of disorders termed telomere biology disorders, including dyskeratosis congenita, idiopathic pulmonary fibrosis, and aplastic anemia. These conditions are characterized by premature aging phenotypes and bone marrow failure.

Telomerase in cancer

Approximately 85-90% of human cancers exhibit reactivated telomerase activity, which enables cancer cells to bypass replicative senescence and achieve immortalization. This reactivation most commonly occurs through upregulation of TERT expression, often via gene amplification, chromosomal rearrangement, or mutations in the TERT promoter region. Such mutations, frequently found in melanoma, glioblastoma, and hepatocellular carcinoma, create new transcription factor binding sites. Consequently, telomerase is a prominent target for cancer therapy, with strategies aimed at inhibiting its activity to limit tumor growth. The presence of telomerase activity is also a diagnostic marker detectable in clinical samples from various malignancies.

Research and therapeutic applications

Research on telomerase spans from basic molecular biology to translational medicine. Efforts to develop telomerase inhibitors include small molecules like BIBR1532, antisense oligonucleotides targeting TERC, and immunotherapy approaches such as GV1001. Conversely, controlled telomerase activation is being explored for treating telomere biology disorders and age-related degenerative conditions, using strategies like gene therapy with TERT or mRNA delivery. The enzyme's role in stem cell biology is critical for regenerative medicine applications. Ongoing studies in model organisms like mice and the budding yeast Saccharomyces cerevisiae continue to elucidate the complex regulation and multifaceted roles of telomerase in health and disease.

Category:Enzymes Category:Molecular biology Category:Oncology